Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05819515 · ClinicalTrials.gov registry record · NA

Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix

A NA study of Gingival Recession, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT05819515 is a NA study of Gingival Recession that has completed, run by University of Michigan. The registered enrollment target is 36 participants, above the 30-participant average among 10 other Gingival Recession trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05819515, a NA study of Gingival Recession, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The study aims to test the non-inferiority of an Allogenic Dermal Matrix with Platelet-Rich Fibrin for treatment of gingival recessions in comparison to the Connective Tissue Graft.

Conditions Studied

Interventions

  • PROCEDURE Tunneled coronally advanced flap

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor - Ann Arbor

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-04-29
Est. Completion 2024-03-27
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05819515

The ClinicalTrials.gov registry entry for NCT05819515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 30-participant average among 10 other Gingival Recession trials with a reported enrollment target (20% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 1 intervention - of which Tunneled coronally advanced flap is the first listed.

NCT05819515 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05819515 about?

NCT05819515 is a clinical study titled "Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix". The study aims to test the non-inferiority of an Allogenic Dermal Matrix with Platelet-Rich Fibrin for treatment of gingival recessions in comparison to the Connective Tissue Graft.

What is the current status of trial NCT05819515?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-04-29. Estimated completion is 2024-03-27.

What conditions does trial NCT05819515 study?

This clinical trial studies the following conditions: Gingival Recession.

What interventions are being tested in trial NCT05819515?

The interventions under investigation include: Tunneled coronally advanced flap (PROCEDURE).

Who is sponsoring clinical trial NCT05819515?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05819515 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingival Recession

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.